Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Jul 26, 2020; 8(14): 2988-2999
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2988
Table 1 Summary of patient characteristics in the older and younger groups
ParameterOverall (n = 614)Age ≥ 80 (n = 146)Age < 80 (n = 468)P value
Age [median (IQR)] (yr)68 (54-79)83 (81-86)62 (50-71)
Charlson score [median (IQR)]0 (0-1)1 (0-2)0 (0-1)0.001a
Charlson score ≥ 221% (129)29.5% (43)18.4% (86)0.005b
ERCP procedure time [median (IQR)] (min)30 (23-45)30 (23-45)30 (24-45)0.711a
Cannulation time [median (IQR)] (min)3.6 (0.8-11.8)3.4 (0.8-11.2)3.7 (0.8-12)0.292a
Male53.2% (327)51.4% (75)53.8% (252)0.636b
Cannulation success rate96.7% (595)96.6% (141)96.8% (454)0.547b
Indications
Biliary stones82.4% (506)82.9% (121)82.3% (385)0.468b
Benign strictures12.7% (78)11% (16)13.2% (62)0.287b
Cholangiocarcinoma4.2% (26)4.8% (7)4.1% (19)0.424b
Cholangitis9.1% (56)6.8% (10)9.8% (46)0.180b
Biliary pancreatitis5.9% (36)4.8% (7)6.2% (29)0.346b
Chronic pancreatitis1.3% (8)0% (0)1.7% (8)0.113b
Ampullary carcinoma3.3% (20)5.5% (8)2.6% (12)0.076b
Pancreatic cancer3.6% (22)2.7% (4)3.8% (18)0.371b
Comorbidities
Hypertension29.5% (181)38.4% (56)26.7% (125)0.009b
Cardiac diseases7.5% (46)15.1% (22)5.1% (24)< 0.001b
Diabetes mellitus11.7% (72)13% (19)11.3% (53)0.558b
Neurological diseases12.5% (77)21.9% (32)9.6% (45)< 0.001b
Hepatic diseases7.8% (48)5.5% (8)8.5% (40)0.290b
Malignancy9.3% (57)11% (16)8.8% (41)0.256b
Others9.9% (61)14.4% (21)8.5% (40)0.031b
Periampullary diverticulum19.7% (121)29.5% (43)16.7% (78)0.001b
Cannulation grade of difficulty
Easy cannulation66% (405)67.1% (98)65.6% (307)0.621b
Moderate cannulation11.7% (72)10.3% (15)12.2% (57)0.658b
Difficult cannulation22.3% (137)22.6% (33)22.2% (104)0.910b
Second ERCP20.4% (125)20.5% (30)20.3% (95)0.512b
Adverse events9.8% (60)13% (19)8.8% (41)0.089b
PEP5.2% (32)2.7% (4)6% (28)0.088b
Perforation0.5% (3)0.7% (1)0.4% (2)0.557b
Bleeding1.9% (12)4.1% (6)1.3% (6)0.111b
Cholangitis0.6% (4)0.7% (1)0.6% (3)0.663b
Cardiopulmonary0.6% (4)0.7% (1)0.6% (3)0.443b
Duration of hospitalization [median (IQR)] (d)9 (6-13)9 (7-13)9 (6-13)0.208a
Pancreatic stent10.4% (64)7.5% (11)11.3% (53)0.124b
Anti-thrombotic drug5.5% (34)7.5% (11)4.9% (23)< 0.001b
Table 2 Summary of causes, cannulation techniques, and adverse events of difficult cannulation patients in the older and younger groups
Overall (n = 209), %Age ≥ 80 (n = 49),%Age < 80 (n = 160), %P value1
Causes of difficulty
Papillary anatomy31.1 (65)18.4 (9)35 (56)0.029
Distal stricture or impacted stone32.5 (68)22.4 (11)35.6 (57)0.108
Diverticulum18.2 (38)26.5 (13)15.6 (25)0.047
Ampullary carcinoma4.8 (10)14.3 (7)1.9 (3)0.001
Altered anatomy8.6 (18)10.2 (5)8.1 (13)0.326
Cannulation failure5.7 (12)8.3 (4)5 (8)0.286
Cannulation techniques
Guidewire assisted42.1 (88)40.8 (20)42.5 (68)0.868
NKP37.7 (79)42.8 (21)36.2 (58)0.239
TPS20.1 (42)16.7 (8)21.2 (34)0.546
Pancreatic stent26.8 (56)22.9 (11)28.1 (45)0.489
Adverse events
PEP10 (21)4.2 (2)11.8 (19)0.096
Perforation1 (2)2.1 (1)0.6 (1)0.407
Bleeding1.9 (4)4.2 (2)1.2 (2)0.227
Cholangitis1.9 (4)2.1 (1)1.9 (3)0.651
Cardiopulmonary1 (2)- (0)1.2 (2)0.593
Table 3 The incidence of adverse events in difficult cannulation cases in the elderly group after repeated guidewire-assisted cannulation, needle knife precut, and transpancreatic sphincterotomy
GuidewireNKPTPSP value1
Adverse eventsn = 20n = 21n = 8
PEP10% (2)- (0)- (0)0.203
Overall adverse events15% (3)14.3% (3)- (0)0.129
Table 4 Multivariate analysis of risk factors for adverse events considering age ≥ 80, Charlson Comorbidity Index ≥ 2, difficult cannulation, ampullary carcinoma, and needle knife precut
Adjusted odds ratio95% Confidence interval
P value
LowerUpper
Adverse events
Age ≥ 801.5680.8612.8540.141
CCI ≥ 21.8240.9933.3490.045
Difficult cannulation3.4781.8776.442< 0.001
Ampullary carcinoma0.5510.1162.6100.453
NKP0.5060.2291.1210.093
Table 5 Multivariate analysis of risk factors for post-endoscopic retrograde cholangiopancreatography considering difficult cannulation, age ≤ 65, female gender, cholangitis, and Charlson Comorbidity Index ≥ 2
Adjusted odds ratio95% Confidence interval
P value
LowerUpper
PEP
Difficult cannulation4.5272.0789.860< 0.001
Age ≤ 65 yr3.4601.5117.9220.003
Female2.3621.0895.1240.030
Cholangitis3.2611.2048.8320.020
CCI ≥ 22.2530.9235.4970.074